inWhite tw_white-black
MoreMenu
CloseWhite
inWhite tw_white-black

News

Asgard Therapeutics appoints Alan Griffith as Chief Development Officer 

Asgard Therapeutics Announces Appointment of Three Members to its Newly Formed Scientific Advisory Board (SAB)

Asgard Therapeutics appoints Martin Bonde as Independent Chair of the Board of Directors

Asgard Therapeutics Granted U.S. Patent for Dendritic Cell Reprogramming

Asgard Therapeutics highlighted as finalist of the 2021 Merck EU Advance Biotech Grants Program

Posted 25 May, 2021